The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients ...

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

Today, mevalonic acid, a compound that plays a key role in the body’s cholesterol production, is emerging as one of ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

Clascoterone cream 1% used twice daily for 2 weeks had no effect on transepidermal water loss of the skin barrier and ...

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

Peptides are essentially proteins in your skin. Some hypotheses suggest they stimulate collagen and lead to skin regeneration ...